Zwitterionic Chitosan Derivatives for Nanoparticle Surface Shielding
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Chitosan derivatives face challenges in parenteral administration due to their potential to activate immune cells and induce inflammatory responses, and cationic dendrimers like PAMAM have non-specific toxicity and interference issues with target cells, limiting their effectiveness in systemic applications.
Innovation Solution
A zwitterionic derivative of chitosan with a tunable pH-dependent charge profile is developed, allowing for safe parenteral use and enhanced compatibility with blood components, combined with PAMAM dendrimers to create nanoparticles that shield cationic surfaces for targeted delivery in acidic environments.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If chitosan is used for parenteral administration, then it provides biocompatible material for drug delivery, but it activates immune cells and induces inflammatory responses
Solution Approach 1:
The patent modifies the chemical parameters of chitosan by introducing zwitterionic groups (carboxymethyl and glycine moieties) to create charge-neutral derivatives. This parameter change transforms the cationic charge profile of native chitosan into a zwitterionic structure with isoelectric points between pH 4-7, eliminating immune activation while preserving biocompatibility and solubility at physiological pH
Solution Approach 2:
The patent creates composite chitosan derivatives by combining chitosan backbone with zwitterionic functional groups (carboxymethyl and glycine). This composite structure integrates the biocompatibility of chitosan with the immune-inert properties of zwitterionic groups, producing a material that is both biocompatible and non-immunogenic for parenteral use
2Ease of operation
If cationic PAMAM dendrimers are used for gene delivery, then they facilitate cellular uptake through cationic charge, but they cause non-specific toxicity and interference with target cells
Solution Approach 1:
The patent modifies the surface charge parameter of PAMAM dendrimers by conjugating them with zwitterionic chitosan derivatives. This transforms the highly cationic surface of native PAMAM into a charge-neutral or mildly cationic surface at physiological pH, reducing non-specific toxicity while preserving gene complexation capability through the dendrimer's internal cationic groups
Solution Approach 2:
The patent creates composite nanoparticle structures by conjugating PAMAM dendrimers with zwitterionic chitosan derivatives. This composite structure combines the gene delivery efficiency of PAMAM dendrimers with the biocompatibility and reduced toxicity of zwitterionic polymers, achieving both effective cellular uptake and reduced harmful effects
3Quantity of substance
If chitosan is deacetylated to increase solubility, then it becomes more water-soluble at acidic pH, but it becomes insoluble at neutral pH limiting parenteral use
Solution Approach 1:
The patent modifies the chemical structure of chitosan by introducing zwitterionic groups (carboxymethyl and glycine) that remain ionized at physiological pH. This parameter change creates a charge-neutral structure with isoelectric points between pH 4-7, ensuring solubility at both acidic and neutral pH conditions required for parenteral administration
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The zwitterionic chitosan derivative reduces immune activation, suppresses inflammatory responses, and facilitates targeted delivery of dendrimers to cells, improving the safety and efficacy of nanoparticle-based drug delivery systems.
Implementation Method 1
The zwitterionic chitosan derivative binds to lipopolysaccharides (LPS), thereby reducing the levels of endotoxins in a composition or in a subject
Implementation Method 2
combined with PAMAM dendrimers to create nanoparticles that shield cationic surfaces for targeted delivery in acidic environments
Data Source
AI summary
The present disclosure provides a polymer comprising a derivative of chitosan, wherein the derivative is zwitterionic, as well as methods of using the polymer. In addition, the present disclosure provides a nanoparticle structure comprising a derivative of chitosan and a dendrimer, as well as methods of utilizing the nanoparticle structure.